Healthcare / Drug Manufacturers - Specialty & GenericUpdated 2026-05-10 22:07 UTC

ZYBT stock hub

Zhengye Biotechnology Holding Limited has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

ZYBTis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

45M

NASDAQ

Market data

Live price

Current market quote for this ticker.

Current price

ZYBT

In the news

Latest news · ZYBT

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12.3P50 18.4P75 33.1

Trailing P/En/a

P25 14.9P50 23.2P75 38.5

ROE-25.2

P25 -105.6P50 -46.5P75 -3.1

ROIC-21.4

P25 -63.1P50 -27.3P75 0.5

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All ZYBT market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

198

Groups with data

Currency

CNY

Showing 198 of 198 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001975641
Company name	Zhengye Biotechnology Holding Limited
Country	China
Country code	US
Cusip	G989MS101
Employees	277
Employees Change	-9%
Employees Change Percent	-3.15
Enterprise value	$48.3M
Exchange	NASDAQ
Financial currency	CNY
First seen	2026-05-09
Industry	Drug Manufacturers - Specialty & Generic
IPO Date	2025-01-07
Isin	KYG989MS1016
Last refreshed	2026-05-10
Market cap	$45M
Market cap category	Nano-Cap
Price	$0.95
Price currency	USD
Rev Per Employee	60,059.39x
Sector	Healthcare
Sic	2834
Symbol	ZYBT
Website	https://www.jlzybio.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-22.17%
EV/FCF	26.66x
EV/Sales	2.9x
FCF yield	4.03%
P/B ratio	1.26x
P/S ratio	2.7x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-60.59%
EBITDA Margin	-38.35%
FCF margin	10.89%
Gross margin	20.51%
Gross Profit	$3.4M
Gross Profit Growth	-73.86%
Gross Profit Growth Q	-90.99%
Gross Profit Growth3 Y	-45.55%
Net Income	$-10M
Net Income Growth Years	0%
Pretax Margin	-61.77%
Profit Margin	-59.97%
Profit Per Employee	$-36,019
ROA	-9.48
ROCE	-22.31
ROE	-25.17
ROIC	-21.37
Roic5y	4.57

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-91.77%
EPS Growth Years	0
FCF Growth	-55.12%
FCF Growth Q	82.72%
OCF Growth	-67.52%
OCF Growth Q	3.58%
OCF Growth3 Y	-8.38%
Revenue Growth	-37.56x
Revenue Growth Q	-40.89x
Revenue Growth Years	0x
Revenue Growth3 Y	-23.53x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.25
Assets	$62.4M
Cash	$7.4M
Current Assets	$20.2M
Current Liabilities	$17.7M
Debt	$10.7M
Debt Equity	$0.24
Debt FCF	$5.92
Equity	$43.9M
Interest Coverage	-20.74
Liabilities	$18.6M
Long Term Assets	$42.2M
Long Term Liabilities	$836,581
Net Cash	$-3.3M
Net Cash By Market Cap	$-7.37
Net Debt Equity	$0.08
Net Debt FCF	$1.83
Tangible Book Value	$27.9M
Tangible Book Value Per Share	$0.59

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.14
Inventory Turnover	1.9
Net Working Capital	$4.4M
Quick ratio	0.58
Working Capital	$2.4M
Working Capital Turnover	$0.59

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-3.78%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-91.76%
200-day SMA	2.87
50-day SMA	0.9
50-day SMA vs 200-day SMA	50under200
All Time High	14.3
All Time High Change	-93.36%
All Time High Date	2025-04-29
All Time Low	0.68
All Time Low Change	39.63%
All Time Low Date	2026-03-16
ATR	0.13
Beta1y	-0.56
Beta2y	-0.46
Ch YTD	-17.43
High	0.98
High52	13.79
High52 Date	2025-05-12
High52ch	-93.11%
Low	0.94
Low52	0.68
Low52 Date	2026-03-16
Low52ch	39.63%
Ma50ch	5.51%
Premarket Change Percent	-5.89
Premarket Price	$0.92
Premarket Volume	375
Price vs 200-day SMA	-66.96%
RSI	50.59
RSI Monthly	41.91
RSI Weekly	40.53
Sharpe ratio	-0.6x
Sortino ratio	-0.81
Total Return	-3.78%
Tr YTD	-17.43
Tr1m	3.54%
Tr1w	3.21%
Tr3m	12.98%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	$-10.1M
Operating margin	-60.59

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	4,418,628%
Float Percent	9.32%
Net Borrowing	-1,799,788.3
Shares Insiders	0.02%
Shares Institutions	0.55%
Shares Out	47,391,376
Shares Qo Q	0.32%
Shares Yo Y	3.78%
Short Float	1.16%
Short Ratio	0.09
Short Shares	0.11

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$1.8M
Average Volume	54,141.45x
Bv Per Share	0.75
CAPEX	$-144,115
Ch1m	3.54
Ch1w	3.21
Ch1y	-91.76
Ch3m	12.98
Ch6m	-53.68
Change	-2.87%
Change From Open	-2.87
Close	0.98
Days Gap	0
Depreciation Amortization	3,805,875.8
Dollar Volume	5,645.7
Earnings Date	2026-04-28
Earnings Time	amc
EBIT	$-10.1M
EBITDA	$-6.4M
EPS	$-0.21
F Score	2
FCF	$1.8M
FCF EV Yield	3.75x
FCF Per Share	$0.04
Financing CF	4,619,410
Fiscal Year End	December
Founded	2,004
Income Tax	$1.6M
Investing CF	-1,805,730
Ipr	-76.26
Iprfo	-74.81
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-04-28
Last Report Date	2025-12-31
Last Split Type	Never
Last10k Filing Date	2026-04-28
Ma150	1.47
Ma150ch	-35.23%
Ma20	0.97
Ma20ch	-2.02%
Net CF	4,536,200
Next Earnings Date	2026-12-11
Open	0.98
Optionable	No
P FCF Ratio	24.83
P OCF Ratio	23.61
Position In Range	25.27
Post Close	0.95
Postmarket Change Percent	3.21
Postmarket Price	$0.98
Ppne	34,890,160
Pre Close	0.98
Price Date	2026-05-08
Ptbv Ratio	1.61
Relative Volume	0.11x
Revenue	16,636,452x
Tax By Revenue	9.53x
Tr6m	-53.68%
Volume	5,946
Z Score	8.39

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does ZYBT pay a dividend?

Capital-return profile for this ticker.

Performance

ZYBT stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns ZYBT?

Insider, institutional, and short-interest positioning.

Institutional ownership

+0.5%

Float: +9.3% of shares outstanding

Insider ownership

+0.0%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

ZYBT momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

50.6

Neutral momentum band

Price vs 200-day MA

-67.0%

50/200-day relationship not available

Beta (5Y)

n/a

Sensitivity to the broader market

Sharpe ratio

-0.60

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About ZYBT

Hub-level FAQ points readers to the deeper analysis pages.

What is the current ZYBT stock rating?

Zhengye Biotechnology Holding Limited is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full ZYBT analysis?

The full report lives at /stocks/ZYBT/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for ZYBT?

The latest report frames ZYBT around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the ZYBT page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.